Sunday, May 31, 2009

Transcriptional profiles of subsets within the CD34+ cell population in chronic phase CML

The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence by Ingmar Bruns and 16 co-authors, including Rainer Haas, Leukemia 2009(May); 23(5): 892-9 [Epub 2009(Jan 22)]. PubMed Abstract:
We found that composition of cell subsets within the CD34+ cell population is markedly altered in chronic phase (CP) chronic myeloid leukemia (CML). Specifically, proportions and absolute cell counts of common myeloid progenitors (CMP) and megakaryocyte-erythrocyte progenitors (MEP) are significantly greater in comparison to normal bone marrow whereas absolute numbers of hematopoietic stem cells (HSC) are equal. To understand the basis for this, we performed gene expression profiling (Affymetrix HU-133A 2.0) of the distinct CD34+ cell subsets from six patients with CP CML and five healthy donors. Euclidean distance analysis revealed a remarkable transcriptional similarity between the CML patients' HSC and normal progenitors, especially CMP. CP CML HSC were transcriptionally more similar to their progeny than normal HSC to theirs, suggesting a more mature phenotype. Hence, the greatest differences between CP CML patients and normal donors were apparent in HSC including downregulation of genes encoding adhesion molecules, transcription factors, regulators of stem-cell fate and inhibitors of cell proliferation in CP CML. Impaired adhesive and migratory capacities were functionally corroborated by fibronectin detachment analysis and transwell assays, respectively. Based on our findings we propose a loss of quiescence of the CML HSC on detachment from the niche leading to expansion of myeloid progenitors.

[Thanks to Alexey Bersenev].

Updates sent to Twitter, May 14-30

Updates about CSC sent to Twitter during May 24-30:

News item: Lung stem cells might cause cancer: http://is.gd/Jd5F Based on OA article [May 29]: http://dx.doi.org/10.1073/pnas.0900668106
[PubMed Citation][Full text of the article is publicly accessible (via Gratis OA)].

Molecular signatures of prostate SC provide insights into prostate cancer (OA) [May 29]: http://dx.doi.org/10.1371/journal.pone.0005722
[PubMed Citation][Full text is publicly accessible (via Libre OA)].

Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective [May 26]: http://www.ncbi.nlm.nih.gov/pubmed/19464789

About inhibition of ABCG2-mediated multidrug resistance as a way to help to eradicate CSC (OA) [May 24]: http://tinyurl.com/q5zzp8
[PubMed Citation][Full text is publicly accessible (via Libre OA)].

Saturday, May 30, 2009

About updates hashtagged #cancerSC

On March 1, 2008, in a post entitled "An experiment with Twitter", I suggested that Twitter might be useful as an adjunct to this blog. The first set of "Updates sent to Twitter" was posted on March 7.

On May 8, 2009, I began adding the hashtag #cancerSC to updates micro-blogged on Twitter.

FriendFeed, described in a Wikipedia entry as a real-time feed aggregator, can be searched for this hashtag. As of today, the results of a search for #cancerSC yielded 15 items. Fourteen of the 15 items are ones that I have micro-blogged on Twitter. All of these 14 items have also been replicated in the weekly "Updates sent to Twitter" that have been posted to this blog.

A FriendFeed search provides a convenient way to review updates that have been hashtagged #cancerSC. Those who have joined FriendFeed can also post comments about individual updates. An advantage of FriendFeed is that, unlike Twitter, comments posted to FriendFeed need not be limited in length to 140 characters.

Short links to individual items can also be created on FriendFeed. These links permit individual items to be shared more widely. For example, the first update that was hashtagged #cancerSC (dated May 8, 2009) can be accessed via: http://ff.im/3pQbI.

Sunday, May 24, 2009

Updates sent to Twitter, May 17-23

Updates about CSC sent to Twitter during May 17-23:

Migration rules: tumours are conglomerates of self-metastases [May 23]: http://dx.doi.org/10.1038/sj.bjc.6605071
[PubMed Citation].

Interferon induces the terminal differentiation of glioma-initiating cells (GICs) [May 23]: http://www.ncbi.nlm.nih.gov/pubmed/19457609

Pro-Cure and Adjuvantix to develop vaccine targeting cancer stem cells [May 23]: http://is.gd/C6Nu
http://www.webcitation.org/5gzbcvRe8

About a Pten knockout mouse prostate cancer model (OA) [May 23]: http://dx.doi.org/10.1371/journal.pone.0005662
[Full text is publicly accessible (via Libre OA)].

Aldehyde Dehydrogenase 1 Is a Putative Marker for Cancer Stem Cells in Head and Neck Squamous Cancer [May 21]: http://bit.ly/wUjsj
[PubMed Citation].

Thursday, May 21, 2009

Some recent Connotea bookmarks tagged "Cancer SC"

Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance, Rosaria Gangemi, Laura Paleari, Anna Maria Orengo, Alfredo Cesario, Leonardo Chessa, Silvano Ferrini, Patrizia Russo, Curr Med Chem 2009; 16(14): 1688-703 [PubMed Citation].

Targeting stem cells-clinical implications for cancer therapy, Lan C Tu, Greg Foltz, Edward Lin, Leroy Hood, Qiang Tian, Curr Stem Cell Res Ther 2009(May); 4(2): 147-53 [PubMed Citation].

TARGETING OF CANCER STEM CELL MARKER EpCAM BY BISPECIFIC ANTIBODY EpCAMxCD3 INHIBITS PANCREATIC CARCINOMA, Alexei V Salnikov and 9 co-authors, J Cell Mol Med 2009(Apr 2) [Epub ahead of print][PubMed Citation].

Number crunching in the cancer stem cell market, Malcolm R Alison, Shahriar Islam, Susan ML Lim, Breast Cancer Res 2009(Apr 24); 11(2): 302 [Epub ahead of print][PubMed Citation].

Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma, Dongho Choi, Hyo Won Lee, Kyung Yul Hur, Jae Joon Kim, Gyeong-Sin Park, Si-Hyong Jang, Young Soo Song, Ki-Seok Jang, and Seung Sam Paik, World J Gastroenterol 2009(May 14_; 15(18): 2258-64 [PubMed Citation][Full text via PMC].

Monday, May 18, 2009

CSC may be related to prognosis in primary breast cancer

Cancer Stem Cells May Be Related To Prognosis In Primary Breast Cancer, ScienceDaily, May 14, 2009. The first two paragraphs:
Breast cancer patients who received chemotherapy prior to surgery had heightened levels of cancer-initiating stem cells in their bone marrow, and the level of such cells correlated to a tumor's lymph node involvement, according to research from The University of Texas M. D. Anderson Cancer Center.
James Reuben, Ph.D., associate professor in the Department of Hematopathology, will present the findings in an oral presentation at the upcoming American Society of Clinical Oncology's annual meeting. It's the first prospective study to investigate the presence of breast cancer stem cells of primary breast cancer patients. The results suggest the need for additional biological therapies, as well as a potential and promising new direction for the study of micro-metastasis.

Updates sent to Twitter, May 10-16

Updates about CSC sent to Twitter during May 10-16:

Cancer stem cells - from initiation to elimination, how far have we reached? (Review) [May 13]: http://bit.ly/qyPOu http://is.gd/zxvj
[PubMed Citation][Full text PDF].

Origins and clinical implications of the brain tumor stem cell hypothesis, J Neurooncol 2009(May 9) [May 13]: http://tinyurl.com/qegc66
[PubMed Citation].

A new epigenetic cancer, Elie Dolgin, The Scientist, 11 May 2009 [May 13]: http://bit.ly/etMRm
[Full text is publicly accessible (free registration is required)].

CD133 may be specifically down-regulated during G0/G1? (PLoS ONE, May 10, 2009) [May 11]: http://tinyurl.com/plbz9c
[Full text is publicly accessible (via Libre OA)].